SCHELLENBERGER VOLKER has a total of 20 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are CB THERAPEUTICS INC, GLYCART BIOTECHNOLOGY AG and COVAGEN AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 20 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Chemical engineering | |
#6 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Enzymes | |
#7 | Fermentation | |
#8 | Chemical or physical processes | |
#9 | Chemical or physical laboratory devices | |
#10 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Schellenberger Volker | 20 |
#2 | Wang Chia-Wei | 14 |
#3 | Stemmer Willem P | 12 |
#4 | Silverman Joshua | 10 |
#5 | Spink Benjamin | 9 |
#6 | Geething Nathan | 7 |
#7 | To Wayne | 4 |
#8 | Cleland Jeffrey L | 4 |
#9 | Gordon Nathaniel C | 4 |
#10 | Crameri Andreas | 4 |
Publication | Filing date | Title |
---|---|---|
US2016137711A1 | Glucagon-like peptide-2 compositions and methods of making and using same | |
US2011172146A1 | Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same | |
US2011077199A1 | Growth hormone polypeptides and methods of making and using same | |
US2008044400A1 | Targeted enzyme prodrug therapy | |
US2005244395A1 | Targeted enzyme prodrug therapy |